The economy is coming out of one of the biggest hits to growth in history, but the stock market has already rebounded to record highs. With so many coronavirus vaccine candidates in trials, there is potential for a big boost in the market. Whether it be Novartis, Pfizer -- which just saw phase 3 of trials begin at Yale for its vaccine candidate -- or a smaller player like Valneva, good news on the vaccine front will be a giant speculative relief for the market as well as for the economy. Read More...
2 Reasons to Invest Now and 2 Reasons to Wait
The economy is coming out of one of the biggest hits to growth in history, but the stock market has already rebounded to record highs. With so many coronavirus vaccine candidates in trials, there is potential for a big boost in the market. Whether it be Novartis, Pfizer — which just saw phase 3 of trials begin at Yale for its vaccine candidate — or a smaller player like Valneva, good news on the vaccine front will be a giant speculative relief for the market as well as for the economy.
Add Comment